World's Best Scientists 2026 revealed!
Gerty Schreibelt

Gerty Schreibelt

D-Index & Metrics

Immunology

D-Index
46
Citations
8547
World Ranking
4613
National Ranking
183

Gerty Schreibelt publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gerty Schreibelt sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 177 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gerty Schreibelt D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gerty Schreibelt sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gerty Schreibelt is affiliated with Radboud University in the Netherlands, focusing on research at the intersection of immunology and oncology. Their work contributes largely to the understanding of immune responses, particularly in the context of cancer immunotherapy.

Their primary fields of study are Immunology and Microbiology, with Medicine also being a significant area of their research portfolio. Subfields include Immunology, Oncology, Molecular Biology, Pathology and Forensic Medicine, and Pulmonary and Respiratory Medicine. Schreibelt's research addresses multiple main topics such as Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, T-cell and B-cell Immunology, vaccines and immunoinformatics approaches, RNA Interference and Gene Delivery, and Immune Cell Function and Interaction.

Schreibelt has contributed to a series of research papers published in prominent scientific venues. Some recent papers include:

  • Trial watch: Dendritic cell (DC)-based immunotherapy for cancer, 2022, OncoImmunology
  • What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings, 2020, Cytotherapy
  • Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial, 2020, Cancer Immunology Immunotherapy
  • Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer, 2021, Frontiers in Immunology
  • Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination, 2020, Cell Reports

Frequent collaborators in Schreibelt's research include:

  • I. Jolanda M. de Vries
  • Kalijn F. Bol
  • Carl G. Figdor
  • Mark A.J. Gorris
  • Georgina Flórez-Grau

The scientist's work has been published repeatedly in certain journals, highlighting ongoing contributions to these outlets. Frequent publication venues are:

  • OncoImmunology
  • Nature Communications
  • Cytotherapy
  • European Journal of Immunology
  • Frontiers in Immunology

Best Publications

  • Radical changes in multiple sclerosis pathogenesis.

    Jack van Horssen;Maarten E. Witte;Gerty Schreibelt;Helga E. de Vries

  • Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling

    Gerty Schreibelt;Gijs Kooij;Arie Reijerkerk;Ruben van Doorn

  • Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

    Jurjen Tel;Erik H.J.G. Aarntzen;Tetsuro Baba;Gerty Schreibelt

  • Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression

    J. van Horssen;G. Schreibelt;J. Drexhage;T. Hazes

  • Dendritic Cell–Based Immunotherapy: State of the Art and Beyond

    Kalijn F. Bol;Gerty Schreibelt;Winald R. Gerritsen;I. Jolanda M. de Vries

  • Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

    W. Joost Lesterhuis;Cornelis J.A. Punt;Stanleyson V. Hato;Dagmar Eleveld-Trancikova

  • Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

    Gerty Schreibelt;Jurjen Tel;Kwinten H. E. W. J. Sliepen;Daniel Benitez-Ribas

  • The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.

    Gerty Schreibelt;Lieke J J Klinkenberg;Luis J Cruz;Paul J Tacken

  • Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

    Gerty Schreibelt;Kalijn F. Bol;Harm Westdorp;Florian Wimmers

  • Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets

    Jurjen Tel;Gerty Schreibelt;Simone P. Sittig;Till S. M. Mathan

  • Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration

    A. C. Inge Boullart;Erik H. J. G. Aarntzen;Pauline Verdijk;Joannes F. M. Jacobs

  • Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients

    W. Joost Lesterhuis;I. Jolanda M. de Vries;Gerty Schreibelt;Annechien J.A. Lambeck

  • Lipoic Acid Affects Cellular Migration into the Central Nervous System and Stabilizes Blood-Brain Barrier Integrity

    Gerty Schreibelt;René J. P. Musters;Arie Reijerkerk;Lody R. de Groot

  • Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets.

    Florian Wimmers;Gerty Schreibelt;Annette E. Sköld;Carl G. Figdor

  • Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell–Based Vaccination

    Erik H.J.G. Aarntzen;I. Jolanda M. De Vries;W. Joost Lesterhuis;Danita Schuurhuis

  • The clinical application of cancer immunotherapy based on naturally circulating dendritic cells

    Kalijn F. Bol;Gerty Schreibelt;Katrin Rabold;Stefanie K. Wculek

  • Trial watch: Dendritic cell (DC)-based immunotherapy for cancer

    Unknown

  • Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time.

    Wouter W. van Willigen;Martine Bloemendal;Winald R. Gerritsen;Gerty Schreibelt

  • Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion

    Jurjen Tel;Simone P. Sittig;Rebecca A. M. Blom;Luis J. Cruz

  • Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients

    Erik H. J. G. Aarntzen;Gerty Schreibelt;Kalijn Bol;W. Joost Lesterhuis

  • Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells.

    Gerty Schreibelt;Daniel Benitez-Ribas;Danita Schuurhuis;Annechien J. A. Lambeck

  • Immunogenicity of Dendritic Cells Pulsed with CEA Peptide or Transfected with CEA mRNA for Vaccination of Colorectal Cancer Patients

    W Joost Lesterhuis;I Jolanda M De Vries;G Schreibelt;Danita H Schuurhuis

Frequent Co-Authors

I. Jolanda M. de Vries
I. Jolanda M. de Vries Radboud University
Carl G. Figdor
Carl G. Figdor Radboud University
Cornelis J. A. Punt
Cornelis J. A. Punt University of Amsterdam
Winald R. Gerritsen
Winald R. Gerritsen Radboud University
Gosse J. Adema
Gosse J. Adema Radboud University
Helga E. de Vries
Helga E. de Vries University of Amsterdam
Christine D. Dijkstra
Christine D. Dijkstra VU University Medical Center
Wim J.G. Oyen
Wim J.G. Oyen Humanitas University
Jack van Horssen
Jack van Horssen Vrije Universiteit Amsterdam
Otto C. Boerman
Otto C. Boerman Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, related healthcare degrees offer diverse career opportunities, especially in nursing and patient care. Exploring options such as accelerated nursing programs can provide a quicker entry into the workforce. For example, the absn programs with high acceptance rates are ideal for those seeking flexibility and accessibility in their studies.

Similarly, those beginning their nursing journey might consider becoming a licensed practical nurse (LPN). Understanding which LPN programs are easiest to get into can help streamline the application process and open doors in healthcare settings related to immunology research and patient care.

As careers progress, nurse practitioners offer specialized skills critical in immunology and related fields. Identifying nurse practitioner programs with easy admission can facilitate advanced training, enabling expanded clinical roles in immunology-focused healthcare.

Mental health also intersects with immunology, where psychiatric-mental health nurse practitioners play a vital role. The best pmhnp programs provide excellent clinical placement opportunities, ensuring practical experience alongside theoretical knowledge.

Overall, these related online degrees and programs offer supportive pathways for those passionate about immunology, emphasizing accessibility, quality clinical training, and career advancement.

Best Scientists Citing Gerty Schreibelt

Trending Scientists

Recently Published Articles